Boston Partners lifted its holdings in Chemed Co. (NYSE:CHE – Free Report) by 51.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,070 shares of the company’s stock after buying an additional 5,787 shares during the period. Boston Partners owned about 0.11% of Chemed worth $9,046,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the business. Pathstone Holdings LLC raised its position in Chemed by 6.0% during the third quarter. Pathstone Holdings LLC now owns 3,694 shares of the company’s stock valued at $2,220,000 after purchasing an additional 210 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Chemed during the 3rd quarter valued at approximately $310,000. Commerce Bank raised its holdings in Chemed by 0.6% during the 3rd quarter. Commerce Bank now owns 6,207 shares of the company’s stock valued at $3,730,000 after buying an additional 40 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Chemed in the third quarter worth $3,835,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in Chemed by 8.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 122,788 shares of the company’s stock worth $73,792,000 after buying an additional 9,178 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, VP Brian C. Judkins acquired 145 shares of the company’s stock in a transaction that occurred on Monday, December 30th. The shares were bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.
Chemed Stock Down 0.3 %
Chemed Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed’s payout ratio is presently 10.05%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on CHE shares. Royal Bank of Canada increased their target price on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.
Check Out Our Latest Analysis on Chemed
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
- Five stocks we like better than Chemed
- How to Use the MarketBeat Dividend Calculator
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- NYSE Stocks Give Investors a Variety of Quality Options
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What is a Low P/E Ratio and What Does it Tell Investors?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.